Newsroom - Zomedica

Zomedica Pharmaceuticals,
TRUFORMA, May Set The Standard In
Pet-Care Diagnostics (NYSE: ZOM)

Transforming Canine Cancer
Detection with ZM-017

Invest in Animal Health

News Releases

Zomedica Completes Verification of Three More Assays for its TRUFORMA™ Point-of-Care Diagnostic Platform

Stories

Click on Detroit, Tech Time with Andrew Humprey: Liquid biopsy is the new way to help diagnose and cure cancer for pets

News Releases

Zomedica Announces First Quarter 2020 Financial Results

Blog

Anne de Vos, DVM: It’s all about perspective

News Releases

Zomedica Completes Verification of its TRUFORMA™ Point-of-Care Diagnostic Platform and the First Assay, Canine total T4

Stories

Zomedica Announces Joint Research Collaboration with CTX Technology, Inc.

News Releases

Zomedica Provides Corporate Update

Blog

Catherine Roach, DVM: Batting 1000 in veterinary medicine

News Releases

Zomedica Pharmaceuticals Corp. Announces Pricing of $4.0 Million Public Offering